BioRestorative Therapies, Inc. (BRTX) Insider Trading Activity

NASDAQ$1.5+0.02 (1.35%)
Market Cap
$2.04M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
456 of 849
Rank in Industry
266 of 491

BRTX Insider Trading Activity

BRTX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100. This treatment involves culturing mesenchymal stem cells harvested from a patient's own bone marrow (autologous) to provide a non-surgical solution for painful lumbosacral disc …

Insider Activity of BioRestorative Therapies, Inc.

Over the last 12 months, insiders at BioRestorative Therapies, Inc. have bought $0 and sold $0 worth of BioRestorative Therapies, Inc. stock.

On average, over the past 5 years, insiders at BioRestorative Therapies, Inc. have bought $646,572 and sold $11,518 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 6,600 shares for transaction amount of $8,250 was made by Silva Francisco (VP of Research and Development) on 2024‑04‑09.

List of Insider Buy and Sell Transactions, BioRestorative Therapies, Inc.

2024-10-28SaleBroadrick Dale10 percent owner
1,112
0.0157%
$1.58
$1,757
+1.90%
2024-04-09PurchaseSilva FranciscoVP of Research and Development
6,600
0.0952%
$1.25
$8,250
+25.78%
2024-04-08PurchaseSilva FranciscoVP of Research and Development
1,708
0.0228%
$1.16
$1,979
+25.00%
2024-02-09PurchaseBroadrick Dale10 percent owner
86,041
1.4895%
$1.32
$113,574
+11.85%
2024-02-08PurchaseBroadrick Dale10 percent owner
157,585
2.6821%
$1.30
$204,508
+17.58%
2024-02-08PurchaseBroadrick Dale10 percent owner
73,959
1.2124%
$1.25
$92,449
+17.58%
2024-02-07PurchaseBroadrick Dale10 percent owner
36,374
0.6583%
$1.38
$50,196
+5.63%
2023-12-01SaleBroadrick Dale10 percent owner
250
0.0053%
$1.88
$469
-15.68%
2023-11-27SaleBroadrick Dale10 percent owner
278
0.0059%
$1.89
$525
-17.37%
2023-09-15PurchaseBroadrick Dale10 percent owner
10,000
0.213%
$1.66
$16,600
-2.69%
2023-09-15PurchaseALSTODT LANCEPresident, CEO, COB
2,200
0.048%
$1.70
$3,740
-2.69%
2023-09-14PurchaseBroadrick Dale10 percent owner
10,000
0.2062%
$1.54
$15,400
+1.88%
2023-09-13PurchaseALSTODT LANCEPresident, CEO, COB
800
0.0161%
$1.53
$1,226
+8.33%
2023-09-07PurchaseBroadrick Dale10 percent owner
2,000
0.044%
$1.86
$3,720
-13.76%
2023-09-06PurchaseALSTODT LANCEPresident, CEO, COB
2,887
0.0638%
$1.96
$5,659
-14.21%
2023-08-31PurchaseSilva FranciscoVP of Research and Development
4,954
0.1071%
$2.22
$10,998
-25.45%
2023-07-28PurchaseBroadrick Dale10 percent owner
500
0.016%
$2.89
$1,445
-39.82%
2023-07-27PurchaseBroadrick Dale10 percent owner
1,000
0.031%
$2.80
$2,800
-39.22%
2023-07-25PurchaseALSTODT LANCEPresident, CEO, COB
4,200
0.1134%
$2.44
$10,248
-29.22%
2023-03-31PurchaseSilva FranciscoVP of Research and Development
747
0.0216%
$3.56
$2,659
-42.35%
Total: 164

Insider Historical Profitability

<0.0001%
Westbury Trust10 percent owner
3115000
225.5403%
$4.61M10
Desmarais John M
455000
32.9441%
$673,400.0020
Broadrick Dale10 percent owner
445933
32.2876%
$659,980.84794
+11.41%
ALSTODT LANCEPresident, CEO, COB
189505
13.721%
$280,467.40330
<0.0001%
Silva FranciscoVP of Research and Development
155759
11.2777%
$230,523.32211
<0.0001%
Tonna Paul Judedirector
123850
8.9673%
$183,298.0040
Weinreb MarkCEO and Chairman of the Board
117000
8.4713%
$173,160.0050
Swiader Joseph Bdirector
100000
7.2405%
$148,000.0010
CATELL ROBERT Bdirector
80866
5.8551%
$119,681.6830
Radov A. Jeffreydirector
24500
1.7739%
$36,260.0040
Ryan Charles S.director
16250
1.1766%
$24,050.0020
Kristal Robert EugeneChief Financial Officer
7994
0.5788%
$11,831.1230

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
BioRestorative Therapies, Inc.
(BRTX)
$633,070
27
-5.89%
$2.04M
$8,249,886
17
-47.87%
$399,787.00
$117,515
16
-27.38%
$1.66M
$1,246,170
12
65.67%
$5.42M

BRTX Institutional Investors: Active Positions

Increased Positions7+30.43%90,193+22.73%
Decreased Positions9-39.13%142,602-35.94%
New Positions3New75,584New
Sold Out Positions4Sold Out62,802Sold Out
Total Postitions21-8.7%344,316-13.21%

BRTX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Citadel Advisors Llc$130.001.18%106,210+106,210New2025-09-30
Vanguard Group Inc$108.000.99%88,778+59,048+198.61%2025-09-30
Geode Capital Management, Llc$67.000.61%55,269+1,007+1.86%2025-09-30
Wealth Alliance, Llc$49.000.44%40,00000%2025-09-30
Stonex Group Inc.$46.000.42%37,450-294-0.78%2025-09-30
Virtu Financial Llc$30.000.27%24,351+12,319+102.39%2025-09-30
State Street Corp$25.000.23%20,45900%2025-09-30
Us Financial Advisors, Llc$21.000.19%17,14200%2025-03-31
Tower Research Capital Llc (Trc)$4.000.04%3,619+2,341+183.18%2025-09-30
Osaic Holdings, Inc.$3.000.02%2,19300%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.